| Emily A Dohrn, OT | |
|
200 1st St Sw, Rochester, MN 55905 | |
| (507) 284-2511 | |
| Not Available |
| Full Name | Emily A Dohrn |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 200 1st St Sw, Rochester, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063645943 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 103750 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Emily A Dohrn, OT 200 1st St Sw, Rochester, MN 55905-0001 Ph: (507) 284-2511 | Emily A Dohrn, OT 200 1st St Sw, Rochester, MN 55905 Ph: (507) 284-2511 |
News Archive
Amgen Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Prolia™ (denosumab) for the treatment of postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other available osteoporosis therapy. Prolia, the first and only FDA-approved RANK Ligand inhibitor, is an every six month 60 mg subcutaneous injection administered by a health care professional.
Shipcom, a leading global provider of enterprise and healthcare solutions, announced today they have been granted Authority to Operate under the DoD Information Assurance Accreditation and Certification Process.
Shire plc, the global specialty biopharmaceutical company, announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency adopted a positive opinion on the marketing authorisation for VPRIV (velaglucerase alfa), the company's enzyme replacement therapy for the treatment of type 1 Gaucher disease.
The European College of Neuropsychopharmacology (ECNP) is pleased to announce Kaj Blennow as the recipient of the 2010 ECNP Neuropsychopharmacology Award in recognition of his original and influential contributions to Alzheimer's disease research. The ECNP Neuropsychopharmacology Award is presented annually and recognises distinguished research in neuropsychopharmacology and closely related disciplines. The award is accompanied by a prize of - 20,000.
› Verified 5 days ago
Amy L Krekelberg, OT Occupational Therapist Medicare: Medicare Enrolled Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Danielle Anshus, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Erika Hope Mckeever, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Deborah Engen, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Susan D Hansen, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Mary B Clark, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Sara Kathleen Tallman, O.T.D. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 |